Skip to content

Postoperative Care of Sutured Wounds

Comparing the Efficacy of Hydrogen Peroxide Versus Normal Saline in Postoperative Care of Sutured Wounds

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02383992
Enrollment
0
Registered
2015-03-10
Start date
2015-10-31
Completion date
2019-10-01
Last updated
2021-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Healing

Brief summary

The primary objective of this study is to compare the efficacy of hydrogen peroxide versus normal saline in postoperative care of sutured wounds. Subjects will be randomly assigned to standard of care hydrogen peroxide or standard of care normal saline in postoperative care of sutured wounds followed by applying petroleum jelly and sterile gauze bandage. Data will be collected at day 0 and between days 7 to14. Subjects will provide irritation scale rating (0-4) with 0 being none/absent and 4 being severe/extreme.

Interventions

DRUG3% H2O2 solution
DRUG0.9% normal saline

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients who are undergoing sutured wound after dermatologic procedure. 2. Males and females ages 18-65 years old. 3. Patients who are in good health. 4. Willingness and the ability to understand and provide informed consent and communicate with the investigator/study staff.

Exclusion criteria

1. History of keloids or hypertrophic scars. 2. History of bleeding tendency or coagulopathy. 3. Pregnant or lactating or intends to become pregnant in the next 3 months. 4. Active skin disease or skin infection in the treatment area. 5. Unable to understand the protocol or to give informed consent. 6. Any other condition that would, in the professional opinion of the investigator, potentially affect response or participation in the clinical clinical study, or would pose as an unacceptable risk to the subject.

Design outcomes

Primary

MeasureTime frameDescription
Irritation scale rating from 1-2 weeks compared to baselineBaseline and 1-2 weeksSubjects will provide irritation scale rating (0-4) with 0 being none/absent and 4 being severe/extreme.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026